Literature DB >> 32711842

MHCflurry 2.0: Improved Pan-Allele Prediction of MHC Class I-Presented Peptides by Incorporating Antigen Processing.

Timothy J O'Donnell1, Alex Rubinsteyn2, Uri Laserson3.   

Abstract

Computational prediction of the peptides presented on major histocompatibility complex (MHC) class I proteins is an important tool for studying T cell immunity. The data available to develop such predictors have expanded with the use of mass spectrometry to identify naturally presented MHC ligands. In addition to elucidating binding motifs, the identified ligands also reflect the antigen processing steps that occur prior to MHC binding. Here, we developed an integrated predictor of MHC class I presentation that combines new models for MHC class I binding and antigen processing. Considering only peptides first predicted by the binding model to bind strongly to MHC, the antigen processing model is trained to discriminate published mass spectrometry-identified MHC class I ligands from unobserved peptides. The integrated model outperformed the two individual components as well as NetMHCpan 4.0 and MixMHCpred 2.0.2 on held-out mass spectrometry experiments. Our predictors are implemented in the open source MHCflurry package, version 2.0 (github.com/openvax/mhcflurry).
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MHC; T cell epitope; antigen processing; epitope prediction

Mesh:

Substances:

Year:  2020        PMID: 32711842     DOI: 10.1016/j.cels.2020.06.010

Source DB:  PubMed          Journal:  Cell Syst        ISSN: 2405-4712            Impact factor:   10.304


  36 in total

Review 1.  Epitope prediction and identification- adaptive T cell responses in humans.

Authors:  John Sidney; Bjoern Peters; Alessandro Sette
Journal:  Semin Immunol       Date:  2020-10-31       Impact factor: 11.130

2.  Markov state modeling reveals alternative unbinding pathways for peptide-MHC complexes.

Authors:  Jayvee R Abella; Dinler Antunes; Kyle Jackson; Gregory Lizée; Cecilia Clementi; Lydia E Kavraki
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-12       Impact factor: 11.205

Review 3.  An Update on "Reverse Vaccinology": The Pathway from Genomes and Epitope Predictions to Tailored, Recombinant Vaccines.

Authors:  Marcin Michalik; Bardya Djahanschiri; Jack C Leo; Dirk Linke
Journal:  Methods Mol Biol       Date:  2022

4.  Promoting the formation of Pi-stacking interaction to improve CTL cells activation between modified peptide and HLA.

Authors:  Ying Zhu; Chang-Xin Huang; Le Zhang; Ze-Fang Wang; Dong-Li Zhao; Fei Ding; Si-Yu Zhang; Yong-Qiang Li; Ling-Zhi Chen
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

5.  Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumors.

Authors:  Assaf Kacen; Aaron Javitt; Matthias P Kramer; David Morgenstern; Tomer Tsaban; Merav D Shmueli; Guo Ci Teo; Felipe da Veiga Leprevost; Eilon Barnea; Fengchao Yu; Arie Admon; Lea Eisenbach; Yardena Samuels; Ora Schueler-Furman; Yishai Levin; Alexey I Nesvizhskii; Yifat Merbl
Journal:  Nat Biotechnol       Date:  2022-10-06       Impact factor: 68.164

Review 6.  Computational cancer neoantigen prediction: current status and recent advances.

Authors:  G Fotakis; Z Trajanoski; D Rieder
Journal:  Immunooncol Technol       Date:  2021-11-20

7.  3pHLA-score improves structure-based peptide-HLA binding affinity prediction.

Authors:  Anja Conev; Didier Devaurs; Mauricio Menegatti Rigo; Dinler Amaral Antunes; Lydia E Kavraki
Journal:  Sci Rep       Date:  2022-06-24       Impact factor: 4.996

8.  A Highly Effective System for Predicting MHC-II Epitopes With Immunogenicity.

Authors:  Shi Xu; Xiaohua Wang; Caiyi Fei
Journal:  Front Oncol       Date:  2022-06-16       Impact factor: 5.738

9.  Ranking-Based Convolutional Neural Network Models for Peptide-MHC Class I Binding Prediction.

Authors:  Ziqi Chen; Martin Renqiang Min; Xia Ning
Journal:  Front Mol Biosci       Date:  2021-05-17

10.  Challenges targeting cancer neoantigens in 2021: a systematic literature review.

Authors:  Ina Chen; Michael Y Chen; S Peter Goedegebuure; William E Gillanders
Journal:  Expert Rev Vaccines       Date:  2021-06-09       Impact factor: 5.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.